1.12 USD
▼-0.01-1.33%
盘后 1.21 0.00%
2026-09-16
市值
$64.64M
市盈率
8.69
EPS
0.13
股息率
—
52 周区间
1.08 – 3.08
成交量
319.54K
Beta
1.48
目标价
—
52W 低 1.0852W 高 3.08
价格走势
公司简介
Spero Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on identifying and developing novel treatments for multi-drug resistant (MDR) bacterial infections and rare diseases in the United States. The company’s product candidates include Tebipenem HBr (tebipenem pivoxil hydrobromide), an oral carbapenem-class antibiotic to treat complicated urinary tract infections, including pyelonephritis for adult patients, which has completed second Phase 3 trial. It has license agreement with Meiji Seika Pharma Co., Ltd. to develop, man...